July 14, 2025Open Access

Development of a Quantitative Systems Pharmacology Model to Interrogate Mitochondrial Metabolism in Heart Failure

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Model examines mitochondrial pathways affecting exercise intolerance in heart failure, indicating potential therapeutic targets.

MAIN FINDING: A quantitative systems pharmacology model reveals mitochondrial dysfunction impacts exercise capacity in heart failure.
KEY EVIDENCE: The model predicts changes in substrate utilization and highlights pyruvate dehydrogenase's role in energy metabolism.
APPROACH: The approach integrates models of oxidative phosphorylation and β-oxidation to interrogate metabolic pathways in heart failure.
SIGNIFICANCE: Understanding these mechanisms aids in developing targeted interventions for exercise intolerance in heart failure patients.

Meyer et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark